IL142063A0 - Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same - Google Patents
Tetrahydropyridoether derivatives and pharmaceutical compositions containing the sameInfo
- Publication number
- IL142063A0 IL142063A0 IL14206399A IL14206399A IL142063A0 IL 142063 A0 IL142063 A0 IL 142063A0 IL 14206399 A IL14206399 A IL 14206399A IL 14206399 A IL14206399 A IL 14206399A IL 142063 A0 IL142063 A0 IL 142063A0
- Authority
- IL
- Israel
- Prior art keywords
- tetrahydropyridoether
- derivatives
- same
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PWILYDZRJORZDR-MISYRCLQSA-N (7r,8r,9r)-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-ol Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(C4=NC(C)=C(C)N4C=C3)N2)OCCOC)=CC=CC=C1 PWILYDZRJORZDR-MISYRCLQSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843504 | 1998-09-23 | ||
| EP98117988 | 1998-09-23 | ||
| PCT/EP1999/006899 WO2000017200A1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL142063A0 true IL142063A0 (en) | 2002-03-10 |
Family
ID=26049024
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14206399A IL142063A0 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same |
| IL142063A IL142063A (en) | 1998-09-23 | 2001-03-18 | History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL142063A IL142063A (en) | 1998-09-23 | 2001-03-18 | History of 10,9,8,7 – Tetrahydro-9 – Phenyl – 8,7,3,2 – Transformed Tetra – Imidazo [2,1–H] [7,1] Neptyridine and pharmaceutical preparations containing them |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6436953B1 (cs) |
| EP (1) | EP1115725B1 (cs) |
| JP (1) | JP4145492B2 (cs) |
| KR (1) | KR100668400B1 (cs) |
| CN (2) | CN1155598C (cs) |
| AT (1) | ATE231862T1 (cs) |
| AU (1) | AU763463B2 (cs) |
| BG (1) | BG65195B1 (cs) |
| BR (1) | BR9914044A (cs) |
| CA (1) | CA2344251A1 (cs) |
| CZ (1) | CZ292335B6 (cs) |
| DE (1) | DE69905178T2 (cs) |
| DK (1) | DK1115725T3 (cs) |
| EA (1) | EA005377B1 (cs) |
| EE (1) | EE04677B1 (cs) |
| ES (1) | ES2191464T3 (cs) |
| GE (1) | GEP20032926B (cs) |
| HK (1) | HK1038360B (cs) |
| HR (1) | HRP20010224A2 (cs) |
| HU (1) | HUP0102990A3 (cs) |
| ID (1) | ID28896A (cs) |
| IL (2) | IL142063A0 (cs) |
| NO (1) | NO317304B1 (cs) |
| NZ (1) | NZ510610A (cs) |
| PL (1) | PL193616B1 (cs) |
| PT (1) | PT1115725E (cs) |
| RS (1) | RS50145B (cs) |
| SI (1) | SI1115725T1 (cs) |
| SK (1) | SK285165B6 (cs) |
| TR (1) | TR200100805T2 (cs) |
| WO (1) | WO2000017200A1 (cs) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS50145B (sr) | 1998-09-23 | 2009-03-25 | Altana Pharma Ag., | Tetrahidropiridoetri |
| ATE240956T1 (de) | 1999-04-17 | 2003-06-15 | Altana Pharma Ag | Haloalkoxy-imidazonaphthyridine |
| CA2721484A1 (en) * | 1999-05-12 | 2000-11-12 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
| BR0109512A (pt) * | 2000-03-29 | 2002-12-17 | Altana Pharma Ag | Imidazopiridinas tricìclicas |
| CA2404474A1 (en) * | 2000-03-29 | 2001-10-04 | Altana Pharma Ag | Prodrugs of imidazopyridine derivatives |
| IL154850A0 (en) * | 2000-10-25 | 2003-10-31 | Altana Pharma Ag | Polysubstituted imidazopyridine derivatives and pharmaceutical compositions containing the same |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| US20040082605A1 (en) * | 2001-03-08 | 2004-04-29 | Arne Eek | Use |
| HUP0400379A3 (en) | 2001-08-02 | 2007-10-29 | Altana Pharma Ag | Tricyclic epoxides and their use for the preparation of pharmaceutically active agents |
| IL159555A0 (en) * | 2001-08-03 | 2004-06-01 | Altana Pharma Ag | Alkyl-substituted imidazopyridine derivatives and pharmaceutical compositions containing the same |
| EP1417208A1 (en) * | 2001-08-03 | 2004-05-12 | ALTANA Pharma AG | Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| US7314935B2 (en) | 2002-02-15 | 2008-01-01 | Altana Pharma Ag | Tricyclic n-acyl compounds |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| CA2484272A1 (en) * | 2002-05-07 | 2003-11-20 | Altana Pharma Ag | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
| JP2006508142A (ja) | 2002-11-19 | 2006-03-09 | アルタナ ファルマ アクチエンゲゼルシャフト | ８−置換イミダゾピリジン |
| PL375819A1 (en) | 2002-12-12 | 2005-12-12 | Altana Pharma Ag | Combination medicament |
| MXPA05006349A (es) * | 2002-12-20 | 2005-08-26 | Altana Pharma Ag | 8-trialquisiloxi -2-metil -9-fenil -7- oxo-7, 8, 9, 10- tetrahidroimidazo [1, 2h] [1, 7]. |
| US20060154954A1 (en) * | 2003-02-17 | 2006-07-13 | Altana Pharma Ag | Combinations and use of selected pharmaceutically active compounds |
| HRP20050399B1 (hr) | 2003-03-10 | 2013-09-30 | Takeda Gmbh | Novi postupci za dobivanje roflumilasta |
| TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
| SA04250092B1 (ar) * | 2003-05-14 | 2008-05-04 | التانا فاروا ايه جي | مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً |
| RS20050868A (en) * | 2003-05-27 | 2007-08-03 | Altana Pharma Ag., | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| MXPA06002139A (es) * | 2003-08-29 | 2006-05-31 | Dynogen Pharmaceuticals Inc | Composiciones utiles para tratar trastornos de la motilidad gastrointestinal. |
| ES2452691T5 (es) | 2003-09-16 | 2022-09-14 | Covis Pharma Gmbh | Uso de ciclesonida para el tratamiento de enfermedades respiratorias |
| CA2544325A1 (en) * | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| EP1697358A1 (en) | 2003-12-19 | 2006-09-06 | Altana Pharma AG | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| NZ549011A (en) * | 2004-02-17 | 2009-04-30 | Altana Pharma Ag | Tricyclic imidazopyridines and intermediates for the synthesis thereof |
| PT1784402E (pt) | 2004-09-03 | 2011-08-23 | Yuhan Corp | Derivados de pirrolo[3,2-c]piridina e processos para a sua preparação |
| PT1784404E (pt) | 2004-09-03 | 2011-12-09 | Yuhan Corp | Derivados de pirrolo[2,3-c]piridina e processos para a sua preparação |
| WO2006038773A1 (en) | 2004-09-03 | 2006-04-13 | Yuhan Corporation | Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| CA2601250C (en) * | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
| EP2080513A1 (en) * | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
| WO2011004882A1 (ja) | 2009-07-09 | 2011-01-13 | ラクオリア創薬株式会社 | 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤 |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
| CA2874988C (en) * | 2012-06-15 | 2016-05-24 | Bio-Pharm Solutions Co., Ltd. | Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same |
| WO2015052256A1 (en) | 2013-10-08 | 2015-04-16 | Katairo Gmbh | Tetrahydropyridoethers for the treatment of stargardt's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| AU615666B2 (en) | 1987-07-16 | 1991-10-10 | Byk Gulden Lomberg Chemische Fabrik Gmbh | New diazols |
| SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| CA2196076A1 (en) * | 1994-07-28 | 1996-02-08 | Gerhard Grundler | Acyl imidazopyridines |
| IL131407A0 (en) * | 1997-03-24 | 2001-01-28 | Byk Gulden Lomberg Chem Fab | Tetrahydropyrido compounds medicaments containing the same and the use thereof |
| HUP0001555A3 (en) * | 1997-10-30 | 2001-01-29 | Altana Pharma Ag | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation |
| RS50145B (sr) | 1998-09-23 | 2009-03-25 | Altana Pharma Ag., | Tetrahidropiridoetri |
-
1999
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active Expired - Fee Related
- 1999-09-17 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 HK HK02100042.6A patent/HK1038360B/en not_active IP Right Cessation
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en active IP Right Grant
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
-
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
-
2002
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
-
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL142063A0 (en) | Tetrahydropyridoether derivatives and pharmaceutical compositions containing the same | |
| HUP0104204A3 (en) | Pyrazolopyridine derivatives as cox-2 inhibitors, process for their preparation and pharmaceutical compositions thereof | |
| HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
| AU2001230892A1 (en) | Orally administered pharmaceutical formulations of benzimidazole derivatives andthe method of preparing the same | |
| HUP0102313A3 (en) | Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates | |
| HUP0101813A3 (en) | Carboxylic acid derivatives substituted by homo- or heterocyclic group preparation method and pharmaceutical compositions containing them | |
| IL136145A0 (en) | Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof | |
| HUP9900457A3 (en) | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents | |
| HUP0103913A3 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
| AU4949800A (en) | 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives | |
| HUP0000450A3 (en) | The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases | |
| HUP0204157A3 (en) | 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same | |
| HUP0002171A3 (en) | Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof | |
| HUP0200816A2 (en) | Substituted 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases, process for their preparation and pharmaceutical compositions containing them | |
| HUP9900386A3 (en) | Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure | |
| AU1774097A (en) | Pharmaceutical compositions for the treatment of rhinitis | |
| HUP0104164A3 (en) | Imidazo[4,5-c]-pyridine-4-one derivatives with factor xa inhibiting effect, pharmaceutical compositions containing the same and process for their preparation | |
| EP1411056A3 (en) | Imidazo[1,2-a]pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for their preparation | |
| IL141165A0 (en) | New imidazopyridine compounds for the inhibition of acid secretion, pharmaceutical compositions thereof and process for preparing the same | |
| HUP0103004A3 (en) | Substituted imidazo[1,2a]azines as selective inhibitors of cox-2, process for their preparation and pharmaceutical compositions containing them | |
| PL352280A1 (en) | Derivatives of naphthyridine, method of making same, use of same and pharmaceutical compositions containing these derivatives | |
| NZ272089A (en) | Quinoline and benzimidazole derivatives; compounds, preparation and pharmaceutical compositions | |
| HUP0202988A3 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
| AU5762099A (en) | The preparation of (n)-substituted-hydroxycycloalkylamine derivatives | |
| PL328123A1 (en) | Derivatives of banzo[c]quinolysine and method of obtaining them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |